ACADIA Pharmaceuticals
ACAD
NZ$34.89
Share price
-4.90%
Change (1 day)
20.25%
Change (1 year)
Categories
ACADIA Pharmaceuticals (ACAD) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : NZ$0.61 Billion
According to ACADIA Pharmaceuticals's latest financial reports the company's total liabilities are NZ$0.61 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
ACADIA Pharmaceuticals - Total liabilities on balance sheet (from 2003 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | NZ$0.80 B | 60.83% |
| 2023-12-31 | NZ$0.50 B | 69.93% |
| 2022-12-31 | NZ$0.29 B | 26.62% |
| 2021-12-31 | NZ$0.23 B | 8.09% |
| 2020-12-31 | NZ$0.21 B | 72.81% |
| 2019-12-31 | NZ$0.12 B | 36.95% |
| 2018-12-31 | NZ$91.12 M | 31.48% |
| 2017-12-31 | NZ$69.3 M | 12.32% |
| 2016-12-31 | NZ$61.7 M | 90.8% |
| 2015-12-31 | NZ$32.33 M | 58.68% |
| 2014-12-31 | NZ$20.38 M | 139.71% |
| 2013-12-31 | NZ$8.5 M | -70.37% |
| 2012-12-31 | NZ$28.69 M | 155.89% |
| 2011-12-31 | NZ$11.21 M | -0.63% |
| 2010-12-31 | NZ$11.28 M | -78.18% |
| 2009-12-31 | NZ$51.72 M | 156.86% |
| 2008-12-31 | NZ$20.13 M | -25.31% |
| 2007-12-31 | NZ$26.95 M | -15.16% |
| 2006-12-31 | NZ$31.77 M | -6.13% |
| 2005-12-31 | NZ$33.84 M | 149.38% |
| 2004-12-31 | NZ$13.57 M | -89.54% |
| 2003-12-31 | NZ$0.12 B | 21.04% |
| 2002-12-31 | NZ$0.10 B | 986.72% |
| 2001-12-31 | NZ$9.86 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Vanda Pharmaceuticals VNDA | NZ$0.20 B | -67.17% | 🇺🇸 USA |
 Pfizer PFE | NZ$195.22 B | 31,875.58% | 🇺🇸 USA |
 Eli Lilly LLY | NZ$122.30 B | 19,931.76% | 🇺🇸 USA |
 Johnson & Johnson JNJ | NZ$192.17 B | 31,377.39% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | NZ$124.69 B | 20,323.18% | 🇺🇸 USA |